• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗生素对流感嗜血杆菌的体外活性

In vitro activity of new antibiotics against Haemophilus influenzae.

作者信息

Machka K, Balg H, Braveny I

机构信息

Institute of Medical Microbiology, Technical University of Munich, FRG.

出版信息

Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):812-4. doi: 10.1007/BF01975058.

DOI:10.1007/BF01975058
PMID:3145871
Abstract

The activity of sulbactam/ampicillin, aztreonam, cefetamet, cefixime, ciprofloxacin, enoxacin, fleroxacin and ofloxacin was determined against 160 Haemophilus influenzae strains using a standardized microdilution method. The strains were categorized into four groups according to beta-lactamase production and their resistance to ampicillin, chloramphenicol, erythromycin, tetracycline and cotrimoxazole. All isolates tested, regardless of their beta-lactamase production or resistance to the above mentioned drugs, were susceptible to the nine antibiotics. The most active antimicrobial agents were aztreonam, cefixime, and the two quinolone derivatives ciprofloxacin and ofloxacin.

摘要

采用标准化微量稀释法测定了舒巴坦/氨苄西林、氨曲南、头孢他美、头孢克肟、环丙沙星、依诺沙星、氟罗沙星和氧氟沙星对160株流感嗜血杆菌的活性。根据β-内酰胺酶产生情况以及它们对氨苄西林、氯霉素、红霉素、四环素和复方新诺明的耐药性,将这些菌株分为四组。所有测试的分离株,无论其β-内酰胺酶产生情况或对上述药物的耐药性如何,均对这9种抗生素敏感。活性最强的抗菌药物是氨曲南、头孢克肟以及两种喹诺酮衍生物环丙沙星和氧氟沙星。

相似文献

1
In vitro activity of new antibiotics against Haemophilus influenzae.新型抗生素对流感嗜血杆菌的体外活性
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):812-4. doi: 10.1007/BF01975058.
2
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
J Antimicrob Chemother. 1987 Nov;20(5):663-9. doi: 10.1093/jac/20.5.663.
3
Comparative susceptibilities of ampicillin and chloramphenicol resistant Haemophilus influenzae to fifteen antibiotics.氨苄西林和氯霉素耐药流感嗜血杆菌对十五种抗生素的敏感性比较
J Antimicrob Chemother. 1987 Mar;19(3):297-301. doi: 10.1093/jac/19.3.297.
4
[In vitro effect of cefixime against Haemophilus influenzae].头孢克肟对流感嗜血杆菌的体外作用
Presse Med. 1989 Oct 11;18(32):1551-2.
5
TEM-1 AND ROB-1 PRESENCE AND ANTIMICROBIAL RESISTANCE IN HAEMOPHILUS INFLUENZAE STRAINS, ISTANBUL, TURKEY.土耳其伊斯坦布尔流感嗜血杆菌菌株中 TEM-1 和 ROB-1 的存在情况及抗菌药物耐药性
Southeast Asian J Trop Med Public Health. 2015 Mar;46(2):254-61.
6
[In vitro sensitivity to antimicrobial agents of Haemophilus influenzae strains isolated from clinical specimens].[从临床标本中分离出的流感嗜血杆菌菌株对抗菌药物的体外敏感性]
Mikrobiyol Bul. 2003 Jan;37(1):19-25.
7
[Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].[2000 - 2002年北京、上海和广州儿童流感嗜血杆菌分离株的抗菌药物敏感性监测]
Zhonghua Yi Xue Za Zhi. 2004 Aug 17;84(16):1335-9.
8
The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.第二项关于流感嗜血杆菌抗菌药物耐药性频率的欧洲协作研究。
Eur J Clin Microbiol Infect Dis. 1990 Nov;9(11):810-7. doi: 10.1007/BF01967379.
9
Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.头孢克肟对来自儿科患者的流感嗜血杆菌分离株(包括耐氨苄西林、不产β-内酰胺酶的分离株)的体外活性比较
Antimicrob Agents Chemother. 1990 Jul;34(7):1456-8. doi: 10.1128/AAC.34.7.1456.
10
In vitro activity of 9 antimicrobial agents against 177 strains of Haemophilus influenzae isolated from hospitalized patients.9种抗菌药物对177株从住院患者中分离出的流感嗜血杆菌的体外活性。
APMIS. 1990 Aug;98(8):753-7.

引用本文的文献

1
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他美酯。其抗菌活性、药代动力学特性及治疗用途综述。
Drugs. 1993 Apr;45(4):589-621. doi: 10.2165/00003495-199345040-00009.
2
[In-vitro activity of enoxacin: a multicenter study].[依诺沙星的体外活性:一项多中心研究]
Infection. 1989;17 Suppl 1:S3-5. doi: 10.1007/BF01643625.
3
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.

本文引用的文献

1
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae.流感嗜血杆菌中非β-内酰胺酶介导的氨苄西林耐药性的特征分析。
Antimicrob Agents Chemother. 1984 Aug;26(2):235-44. doi: 10.1128/AAC.26.2.235.
2
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.氨曲南:抗菌活性、β-内酰胺酶稳定性以及纸片扩散法药敏试验的解释标准和质量控制指南
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S594-604. doi: 10.1093/clinids/7.supplement_4.s594.
3
[Prevalence of antibiotic resistance of Haemophilus influenzae isolated in France: a year of activities of the network of surveillance for H. influenzae infections].
头孢克肟与其他口服抗生素对含BRO-1和BRO-2的成人卡他莫拉菌(布兰汉菌属)临床分离株及流感嗜血杆菌的活性比较。
Antimicrob Agents Chemother. 1991 Jan;35(1):192-4. doi: 10.1128/AAC.35.1.192.
4
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.
5
Fleroxacin clinical pharmacokinetics.氟罗沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Feb;22(2):116-31. doi: 10.2165/00003088-199222020-00003.
[法国分离出的流感嗜血杆菌的抗生素耐药性患病率:流感嗜血杆菌感染监测网络的一年活动]
Pathol Biol (Paris). 1986 May;34(5):372-8.
4
In vitro susceptibility of Haemophilus influenzae to cefixime.流感嗜血杆菌对头孢克肟的体外敏感性
Antimicrob Agents Chemother. 1987 Nov;31(11):1841-2. doi: 10.1128/AAC.31.11.1841.
5
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
J Antimicrob Chemother. 1987 Nov;20(5):663-9. doi: 10.1093/jac/20.5.663.
6
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.流感嗜血杆菌临床分离株中抗菌药物耐药性流行情况的全国性协作研究。
Antimicrob Agents Chemother. 1988 Feb;32(2):180-5. doi: 10.1128/AAC.32.2.180.
7
Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.流感嗜血杆菌的分布及耐药模式:一项欧洲合作研究。
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):14-24. doi: 10.1007/BF01962165.
8
Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S528-34. doi: 10.1093/clinids/8.supplement_5.s528.
9
Chloramphenicol resistance in Haemophilus influenzae.流感嗜血杆菌对氯霉素的耐药性。
Lancet. 1976 Mar 27;1(7961):702. doi: 10.1016/s0140-6736(76)92832-4.
10
Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin.对氨苄西林耐药的B型流感嗜血杆菌,具有TEM型β-内酰胺酶,但对氨苄西林的通透屏障较弱。
Lancet. 1975 Mar 29;1(7909):716-9. doi: 10.1016/s0140-6736(75)91630-x.